{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ROS", "Topoisomerase I", "apoptosis", "cancer", "cell death", "cisplatin", "combinatorial therapy", "toxicity"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30061495", "DateCompleted": {"Year": "2018", "Month": "11", "Day": "09"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "07", "Day": "30"}], "Language": ["eng"], "ELocationID": ["2219", "10.3390/ijms19082219"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "19", "Issue": "8", "PubDate": {"Year": "2018", "Month": "Jul", "Day": "30"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "<i>Asteriscus graveolens</i> Extract in Combination with Cisplatin/Etoposide/Doxorubicin Suppresses Lymphoma Cell Growth through Induction of Caspase-3 Dependent Apoptosis.", "Abstract": {"AbstractText": ["Chemotherapy drugs action against cancer is not selective, lead to adverse reactions and drug resistance. Combination therapies have proven more effective in defeating cancers. We hypothesize that plant extract/fraction contains many/several compounds and as such can target multiple pathways as cytotoxic agent and may also have chemo sensitizing activities. We designed a study in which, <i>Asteriscus graveolens</i> (<i>Forssk.</i>) <i>Less</i> (<i>A. graveolens</i>)-derived fraction that contains sesquiterpene lactone asteriscunolide isomers (AS) will be tested in combination with known chemotherapy drugs. Successful combination will permit to reduce chemotherapy drugs concentration and still get the same impact on cancer cells. Sesquiterpene lactone such as asteriscunolide isomers is a naturally occurring compound found in a variety of fruits, vegetables, and medicinal plants with anti-cancer properties. The experiments presented here showed that adding plant fraction containing AS permit reducing the concentration of cisplatin/etoposide/doxorubicin in order to reduce mouse BS-24-1 lymphoma cells (BS-24-1 cells) survival. It involved enhancing the production of Reactive Oxygen Species (ROS), activation of caspase-3 and inhibition of Topoisomerase I activity. Taken together, the results suggest that <i>A. graveolens</i> fraction sensitized BS-24-1 cells to cisplatin/etoposide/doxorubicin through induction of ROS and caspase-3-dependent apoptosis."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dead Sea & Arava Science Center, Sapir 868215, Israel. zainab_tayeh@yahoo.com."}, {"Identifier": [], "Affiliation": "French Assoc. Inst. for Agriculture and Biotechnology of Drylands, Jacob Blaustein Institutes for Desert Research, Ben-Gurion University of the Negev, Midreshet Ben-Gurion 8499000, Israel. zainab_tayeh@yahoo.com."}], "LastName": "Tayeh", "ForeName": "Zainab", "Initials": "Z"}, {"Identifier": ["0000-0002-7580-0163"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dead Sea & Arava Science Center, Sapir 868215, Israel. rivir@bgu.ac.il."}, {"Identifier": [], "Affiliation": "Regenerative Medicine &Stem Cell Research Center, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel. rivir@bgu.ac.il."}], "LastName": "Ofir", "ForeName": "Rivka", "Initials": "R"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Lactones"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Sesquiterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "asteriscunolide A"}, {"RegistryNumber": "6PLQ3CP4P3", "NameOfSubstance": "Etoposide"}, {"RegistryNumber": "80168379AG", "NameOfSubstance": "Doxorubicin"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "Caspase 3"}, {"RegistryNumber": "Q20Q21Q62J", "NameOfSubstance": "Cisplatin"}], "SupplMeshList": ["EAP protocol"], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Combined Chemotherapy Protocols"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["chemistry"], "DescriptorName": "Asteraceae"}, {"QualifierName": ["metabolism"], "DescriptorName": "Caspase 3"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Cisplatin"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Doxorubicin"}, {"QualifierName": [], "DescriptorName": "Drug Synergism"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Etoposide"}, {"QualifierName": [], "DescriptorName": "Isomerism"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Lactones"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Lymphoma"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Sesquiterpenes"}], "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Feitelson M.A., Arzumanyan A., Kulathinal R.J., Blain S.W., Holcombe R.F., Mahajna J., Marino M., Martinez-Chantar M.L., Nawroth R., Sanchez-Garcia I., et al. Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin. Cancer Biol. 2015;35:S25\u2013S54. doi: 10.1016/j.semcancer.2015.02.006.", "ArticleIdList": ["10.1016/j.semcancer.2015.02.006", "PMC4898971", "25892662"]}, {"Citation": "Plati J., Bucur O., Khosravi-Far R. Dysregulation of Apoptotic Signaling in Cancer: Molecular Mechanisms and Therapeutic Opportunities. J. Cell. Biochem. 2008;104:1124\u20131149. doi: 10.1002/jcb.21707.", "ArticleIdList": ["10.1002/jcb.21707", "PMC2941905", "18459149"]}, {"Citation": "Biswal S.G., Mehta R.D. Cutaneous Adverse Reactions of Chemotherapy in Cancer Patients: A Clinicoepidemiological Study. Indian J. Dermatol. 2018;63:41\u201346. doi: 10.4103/ijd.IJD_65_17.", "ArticleIdList": ["10.4103/ijd.IJD_65_17", "PMC5838753", "29527024"]}, {"Citation": "Housman G., Byler S., Heerboth S., Lapinska K., Longacre M., Snyder N., Sarkar S. Drug Resistance in Cancer: An Overview. Cancers. 2014;6:1769\u20131792. doi: 10.3390/cancers6031769.", "ArticleIdList": ["10.3390/cancers6031769", "PMC4190567", "25198391"]}, {"Citation": "Aung T.N., Qu Z., Kortschak R.D., Adelson D.L. Understanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action. Int. J. Mol. Sci. 2017;18:656. doi: 10.3390/ijms18030656.", "ArticleIdList": ["10.3390/ijms18030656", "PMC5372668", "28304343"]}, {"Citation": "Zhu P., Aliabadi H.M., Uluda\u011f H., Han J. Identification of Potential Drug Targets in Cancer Signaling Pathways using Stochastic Logical Models. Sci. Rep. 2016;6:23078. doi: 10.1038/srep23078.", "ArticleIdList": ["10.1038/srep23078", "PMC4796823", "26988076"]}, {"Citation": "Florea A.-M., B\u00fcsselberg D. Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects. Cancers. 2011;3:1351\u20131371. doi: 10.3390/cancers3011351.", "ArticleIdList": ["10.3390/cancers3011351", "PMC3756417", "24212665"]}, {"Citation": "Wang K., Wu X., Wang J., Huang J. Cancer stem cell theory: Therapeutic implications for nanomedicine. Int. J. Nanomed. 2013;8:899\u2013908.", "ArticleIdList": ["PMC3589204", "23467584"]}, {"Citation": "Burz C., Berindan-Neagoe I., Balacescu O., Irimie A. Apoptosis in cancer: Key molecular signaling pathways and therapy targets. Acta Oncol. 2009;48:811\u2013821. doi: 10.1080/02841860902974175.", "ArticleIdList": ["10.1080/02841860902974175", "19513886"]}, {"Citation": "Daenen L.G.M., Houthuijzen J.M., Cirkel G.A., Roodhart J.M.L., Shaked Y., Voest E.E. Treatment-induced host-mediated mechanisms reducing the efficacy of antitumor therapies. Oncogene. 2013;33:1341\u20131347. doi: 10.1038/onc.2013.94.", "ArticleIdList": ["10.1038/onc.2013.94", "23524584"]}, {"Citation": "Brozovic A., Ambriovi\u0107-Ristov A., Osmak M. The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin. Crit. Rev. Toxicol. 2010;40:347\u2013359. doi: 10.3109/10408441003601836.", "ArticleIdList": ["10.3109/10408441003601836", "20163198"]}, {"Citation": "Denisenko T.V., Budkevich I.N., Zhivotovsky B. Cell death-based treatment of lung adenocarcinoma. Cell Death Dis. 2018;9:117. doi: 10.1038/s41419-017-0063-y.", "ArticleIdList": ["10.1038/s41419-017-0063-y", "PMC5833343", "29371589"]}, {"Citation": "Riquelme I., Saavedra K., Espinoza J.A., Weber H., Garc\u00eda P., Nervi B., Garrido M., Corval\u00e1n A.H., Roa J.C., Bizama C. Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy. Oncotarget. 2015;6:24750\u201324779. doi: 10.18632/oncotarget.4990.", "ArticleIdList": ["10.18632/oncotarget.4990", "PMC4694793", "26267324"]}, {"Citation": "Ricci M.S., Zong W.-X. Chemotherapeutic Approaches for Targeting Cell Death Pathways. Oncologist. 2006;11:342\u2013357. doi: 10.1634/theoncologist.11-4-342.", "ArticleIdList": ["10.1634/theoncologist.11-4-342", "PMC3132471", "16614230"]}, {"Citation": "Marullo R., Werner E., Degtyareva N., Moore B., Altavilla G., Ramalingam S.S., Doetsch P.W. Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions. PLoS ONE. 2013;8:e81162. doi: 10.1371/journal.pone.0081162.", "ArticleIdList": ["10.1371/journal.pone.0081162", "PMC3834214", "24260552"]}, {"Citation": "Pendleton M., Lindsey R.H., Felix C.A., Grimwade D., Osheroff N. Topoisomerase II and leukemia. Ann. N. Y. Acad. Sci. 2014;1310:98\u2013110. doi: 10.1111/nyas.12358.", "ArticleIdList": ["10.1111/nyas.12358", "PMC3961513", "24495080"]}, {"Citation": "Giovanella B., Stehlin J., Wall M.E., Wani M.C., Nicholas A.W., Liu L.F., Silber R., Potmesil M. DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts. Science. 1989;246:1046\u20131048. doi: 10.1126/science.2555920.", "ArticleIdList": ["10.1126/science.2555920", "2555920"]}, {"Citation": "Burgess D.J., Doles J., Zender L., Xue W., Ma B., McCombie W.R., Hannon G.J., Lowe S.W., Hemann M.T. Topoisomerase levels determine chemotherapy response in vitro and in vivo. Proc. Natl. Acad. Sci. USA. 2008;105:9053\u20139058. doi: 10.1073/pnas.0803513105.", "ArticleIdList": ["10.1073/pnas.0803513105", "PMC2435590", "18574145"]}, {"Citation": "Mokhtari R.B., Homayouni T.S., Baluch N., Morgatskaya E., Kumar S., Das B., Yeger H. Combination therapy in combating cancer. Oncotarget. 2017;8:38022\u201338043. doi: 10.18632/oncotarget.16723.", "ArticleIdList": ["10.18632/oncotarget.16723", "PMC5514969", "28410237"]}, {"Citation": "Dasari S., Tchounwou P.B. Cisplatin in cancer therapy: Molecular mechanisms of action. Eur. J. Pharmacol. 2014;740:364\u2013378. doi: 10.1016/j.ejphar.2014.07.025.", "ArticleIdList": ["10.1016/j.ejphar.2014.07.025", "PMC4146684", "25058905"]}, {"Citation": "Li L., Huang X., Huang R., Gou S., Wang Z., Wang H. Pt(IV) prodrugs containing microtubule inhibitors displayed potent antitumor activity and ability to overcome cisplatin resistance. Eur. J. Med. Chem. 2018;156:666\u2013679. doi: 10.1016/j.ejmech.2018.07.016.", "ArticleIdList": ["10.1016/j.ejmech.2018.07.016", "30031977"]}, {"Citation": "Basu A., Krishnamurthy S. Cellular Responses to Cisplatin-Induced DNA Damage. J. Nucleic Acids. 2010;2010:201367. doi: 10.4061/2010/201367.", "ArticleIdList": ["10.4061/2010/201367", "PMC2929606", "20811617"]}, {"Citation": "Steele V.E., Lubet R.A. The Use of Animal Models for Cancer Chemoprevention Drug Development. Semin. Oncol. 2010;37:327\u2013338. doi: 10.1053/j.seminoncol.2010.05.010.", "ArticleIdList": ["10.1053/j.seminoncol.2010.05.010", "PMC2935905", "20816503"]}, {"Citation": "Khafif A., Schantz S.P., Chou T.C., Edelstein D., Sacks P.G. Quantitation of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells. Carcinogenesis. 1998;19:419\u2013424. doi: 10.1093/carcin/19.3.419.", "ArticleIdList": ["10.1093/carcin/19.3.419", "9525275"]}, {"Citation": "Greco W.R., Park H.S., Rustum Y.M. Application of a New Approach for the Quantitation of Drug Synergism to the Combination of cis-Diamminedichloroplatinum and 1-\u03b2-d-Arabinofuranosylcytosine. Cancer Res. 1990;50:5318\u20135327.", "ArticleIdList": ["2386940"]}, {"Citation": "Batra P., Sharma A.K. Anti-cancer potential of flavonoids: Recent trends and future perspectives. 3 Biotech. 2013;3:439\u2013459. doi: 10.1007/s13205-013-0117-5.", "ArticleIdList": ["10.1007/s13205-013-0117-5", "PMC3824783", "28324424"]}, {"Citation": "Chahar M.K., Sharma N., Dobhal M.P., Joshi Y.C. Flavonoids: A versatile source of anticancer drugs. Pharmacogn. Rev. 2011;5:1\u201312.", "ArticleIdList": ["PMC3210013", "22096313"]}, {"Citation": "Prakash O., Kumar A., Kumar P. Anticancer Potential of Plants and Natural Products: A Review. Am. J. Pharmacol. Sci. 2013;1:104\u2013115. doi: 10.12691/ajps-1-6-1.", "ArticleIdList": ["10.12691/ajps-1-6-1"]}, {"Citation": "Millimouno F.M., Dong J., Yang L., Li J., Li X. Targeting Apoptosis Pathways in Cancer and Perspectives with Natural Compounds from Mother Nature. Cancer Prev. Res. 2014;7:1081\u20131107. doi: 10.1158/1940-6207.CAPR-14-0136.", "ArticleIdList": ["10.1158/1940-6207.CAPR-14-0136", "25161295"]}, {"Citation": "Faiza C., Allali H., Bennaceur M., Flamini G. Chemical Composition and Antimicrobial Activity of Essential Oils from the Aerial Parts of Asteriscus graveolens (FORSSK.) LESS. and Pulicaria incisa (LAM.) DC.: Two Asteraceae Herbs Growing Wild in the Hoggar. Chem. Biodivers. 2017;14:e1700092.", "ArticleIdList": ["28467692"]}, {"Citation": "Cristofari G., Znini M., Majidi L., Mazouz H., Tomi P., Costa J., Paolini J. Chemical Diversity of Essential Oils from Asteriscus graveolens (Forssk.) Less.: Identification of cis-8-Acetoxychrysanthenyl Acetate as a New Natural Component. Chem. Biodivers. 2012;9:727\u2013738. doi: 10.1002/cbdv.201100118.", "ArticleIdList": ["10.1002/cbdv.201100118", "22492491"]}, {"Citation": "Hayet E., Saleem A., Souad L., Mahjoub M.A., Mastouri M., Aouni M., Mighri Z., Verschaeve L. In vitro evaluation of antimicrobial and antioxidant activities of some Tunesian vegetables. S. Afr. J. Bot. 2012;78:252\u2013256."}, {"Citation": "Znini M., Cristofari G., Majidi L., Mazouz H.A.M.I.D., Tomi P., Paolini J.U.L.I.E.N., Costa J. Antifungal Activity of Essential Oil from Asteriscus graveolens against Postharvest Phytopathogenic Fungi in Apples. Nat. Prod. Commun. 2011;6:1763\u20131768.", "ArticleIdList": ["22224306"]}, {"Citation": "Tayeh Z., Dudai N., Schechter A., Chalifa-Caspi V., Barak S., Ofir R. Molecular Mode of Action of Asteriscus graveolens as an Anticancer Agent. Int. J. Mol. Sci. 2018;19:2162. doi: 10.3390/ijms19082162.", "ArticleIdList": ["10.3390/ijms19082162", "PMC6121366", "30042356"]}, {"Citation": "Negr\u00edn G., Eiroa J.L., Morales M., Triana J., Quintana J., Est\u00e9vez F. Naturally occurring asteriscunolide A induces apoptosis and activation of mitogen-activated protein kinase pathway in human tumor cell lines. Mol. Carcinogen. 2010;49:488\u2013499. doi: 10.1002/mc.20629.", "ArticleIdList": ["10.1002/mc.20629", "20232365"]}, {"Citation": "Wolfson M., Aboud M., Ofir R., Weinstein Y., Segal S. Modulation of protein kinase C and Ca2+ lipid-independent protein kinase in lymphoma induced by moloney murine leukemia virus in BALB/c mice. Int. J. Cancer. 1986;37:589\u2013593. doi: 10.1002/ijc.2910370418.", "ArticleIdList": ["10.1002/ijc.2910370418", "3957464"]}, {"Citation": "Hila N., Tatiana R., Yizhak A., Mizrahi S., Avni Y.S., Taube R., Rager B., Weinstein Y., Rall G., Gopas J., et al. Measles Virus Persistent Infection of Human Induced Pluripotent Stem Cells. Cell. Reprogram. 2018;20:17\u201326.", "ArticleIdList": ["PMC5804099", "29412740"]}, {"Citation": "Zhang N., Fu J.-N., Chou T.-C. Synergistic combination of microtubule targeting anticancer fludelone with cytoprotective panaxytriol derived from panax ginseng against MX-1 cells in vitro: Experimental design and data analysis using the combination index method. Am. J. Cancer Res. 2016;6:97\u2013104.", "ArticleIdList": ["PMC4759401", "27073727"]}, {"Citation": "Raza M.H., Siraj S., Waheed U., Aldakheel F., Alduraywish S., Arshad M. ROS-modulated therapeutic approaches in cancer treatment. J. Cancer Res. Clin. Oncol. 2017;143:1789\u20131809.", "ArticleIdList": ["28647857"]}, {"Citation": "De S\u00e1 Junior P.L., C\u00e2mara D.A.D., Porcacchia A.S., Fonseca P.M.M., Jorge S.D., Araldi R.P., Ferreira A.K. The Roles of ROS in Cancer Heterogeneity and Therapy. Oxid. Med. Cell. Longev. 2017;2017:2467940. doi: 10.1155/2017/2467940.", "ArticleIdList": ["10.1155/2017/2467940", "PMC5662836", "29123614"]}, {"Citation": "Babaei G., Aliarab A., Rasmi Y., Aziz S.G.G. Application of sesquiterpene lactone: A new promising way for cancer therapy based on anticancer activity. Biomed. Pharmacother. 2018;106:239\u2013246. doi: 10.1016/j.biopha.2018.06.131.", "ArticleIdList": ["10.1016/j.biopha.2018.06.131", "29966966"]}, {"Citation": "Wang L., Qin W., Tian L., Zhang X.X., Lin F., Cheng F., Chen J.F., Liu C.X., Guo Z.Y., Proksch P., et al. Caroguaianolide A\u2013E, five new cytotoxic sesquiterpene lactones from Carpesium abrotanoides, L. Fitoterapia. 2018;127:349\u2013355. doi: 10.1016/j.fitote.2018.03.015.", "ArticleIdList": ["10.1016/j.fitote.2018.03.015", "29621599"]}, {"Citation": "Dudai N., Weinstein Y., Krup M., Rabinski T., Ofir R. Citral is a New Inducer of Caspase-3 in Tumor Cell Lines. Planta Med. 2005;71:484\u2013488. doi: 10.1055/s-2005-864146.", "ArticleIdList": ["10.1055/s-2005-864146", "15931590"]}]}], "History": [{"Year": "2018", "Month": "7", "Day": "5"}, {"Year": "2018", "Month": "7", "Day": "25"}, {"Year": "2018", "Month": "7", "Day": "28"}, {"Year": "2018", "Month": "8", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "8", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "11", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "8", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["30061495", "PMC6122010", "10.3390/ijms19082219", "ijms19082219"]}}]}